Literature DB >> 3839015

Prostanoids in hemolytic uremic syndrome.

M J Stuart, R E Spitzer, R W Walenga, S Boone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3839015     DOI： 10.1016/s0022-3476(85)80243-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis.

Authors:  C M Taylor; C J Lote
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

Review 2.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 3.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

4.  Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.

Authors:  M R Ogborn; J F Crocker; D R Barnard
Journal:  CMAJ       Date:  1990-12-15       Impact factor: 8.262

5.  Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.

Authors:  A N Alam; N M Abdal; M A Wahed; B Rao; C A Kawser; M Hoque; M M Rahaman
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 6.  Prostacyclin in diarrhoea-associated haemolytic uraemic syndrome.

Authors:  C M Taylor; C J Lote
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.